Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...

Biopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...

Biocon Biologics' drug substance facility in Bengaluru has been classified as Voluntary Action Indicated (VAI) by the USFDA. This classific...

Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will supply the insu...

Biocon Biologics' drug substance facility in Bengaluru has been classified by the USFDA as voluntary action indicated after a cGMP inspecti...

The agreement licenses the company to launch in the US in February 2025, once approved by the US Food and Drug Administration(USFDA), Bioco...

The US drug regulator issued 6 observations for drug substance, drug product units and quality Control laboratories and 2 observations for ...

The agency in its charge sheet filed last week has annexed alleged incriminating WhatsApp texts exchanged between alleged conduit (a woman)...

The special CBI court, in an 80-page order rejecting the bail pleas of all five accused in the case earlier this week, said: "The questions...

A special court here had sent all the five accused, including a joint drug controller at Central Drugs Standard Control Organisation, to ju...

The CBI has arrested Joint Drugs Controller S Eswara Reddy, Associate Vice President of Biocon Biologics L Praveen Kumar and three others i...

"To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the standard revie...

True North has acquired about 3 per cent of Biocon Biologics India Ltd (BBIL), a wholly owned subsidiary of Biocon, for $100 million, valui...

This additional approval of its new manufacturing facility for pegfilgrastim in Bengaluru will enable the biotechnology major to enable its...

Biopharma major Biocon reportedly received an Establishment Inspection Report (EIR) from US-FDA for its biologics drug product unit at Beng...

Biosimilars are identical copies of highly complex biologic drugs that are said to have the same efficacy.

"The company has received market authorisation from the DCGI for its novel biologic Itolizumab, for treatment of chronic plaque psoriasis,"...